Diabetes Care Devices - Indonesia

In Indonesia, revenue in the Diabetes Care Devices market market is projected to reach US$186.00m in 2024.
The revenue is expected to demonstrate an annual growth rate (CAGR 2024-2029) of 13.47%, leading to a market volume of US$350.00m by 2029.
In a global context, the majority of revenue will be generated the United States, which is anticipated to reach US$11.71bn in 2024.
Indonesia is experiencing a surge in demand for innovative diabetes care devices, driven by a growing prevalence of diabetes and increasing health awareness among its population.

Definition:
The Diabetes Care Devices market, a medical technology market, includes medical devices used in the management and treatment of diabetes. These devices range from blood glucose meters and continuous glucose monitoring systems to insulin pumps, insulin pens, and other related accessories. It is important to note that the market does not include pharmaceutical products used in the treatment of diabetes, such as insulin and oral hypoglycemic agents.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B), and governments (B2G). Revenues are allocated to the country where the money is spent.

Key players in the market include Medtronic, Abbott Laboratories, and Roche Diagnostics. Further information on the key players can be found in the Market Shares boxes.

Blood glucose monitoring devices
Insulin delivery devices

Diabetes drugs
Diabetes supplements

The Diabetes Care Devices Market in Indonesia is witnessing considerable growth, fueled by factors such as increasing prevalence of diabetes, advancements in technology, heightened awareness of diabetes management, and the rising demand for home healthcare solutions.

Customer preferences: Consumers in Indonesia are increasingly prioritizing personalized diabetes management solutions, leading to a rising interest in connected glucose monitoring devices and mobile health applications. The cultural emphasis on family health and support has heightened demand for user-friendly devices that facilitate shared management among family members. Additionally, the growing middle-class demographic is driving a preference for innovative, affordable, and accessible diabetes care options, reflecting a shift towards proactive health management and preventive care practices in everyday life.

Trends in the market: In Indonesia, the Diabetes Care Devices Market is experiencing a surge in demand for connected glucose monitoring devices and mobile health applications, driven by consumers' desire for personalized diabetes management. This trend reflects a cultural emphasis on family health, as user-friendly devices that enable shared monitoring among family members are increasingly sought after. The expanding middle-class demographic is also pushing for innovative, affordable, and accessible options, indicating a shift towards proactive health management. These developments present significant opportunities for industry stakeholders to enhance product offerings and improve patient engagement, ultimately shaping the future of diabetes care in the region.

Local special circumstances: In Indonesia, the Diabetes Care Devices Market is influenced by a diverse population and varying levels of healthcare access across urban and rural areas. The country's unique geographical landscape poses challenges in distribution, prompting innovative solutions like mobile health applications that bridge gaps in care. Culturally, the communal approach to health encourages family involvement in diabetes management, driving demand for connected devices. Additionally, regulatory support for medical technology innovation fosters a competitive environment, enabling stakeholders to develop tailored, cost-effective solutions that resonate with local needs.

Underlying macroeconomic factors: The Diabetes Care Devices Market in Indonesia is significantly shaped by macroeconomic factors such as national economic growth, healthcare expenditure, and global market trends. As Indonesia's economy expands, increased disposable income allows for greater healthcare spending, enhancing access to diabetes care devices. The government's fiscal policies aimed at boosting healthcare infrastructure and promoting medical technology innovation further support market growth. Additionally, the rising prevalence of diabetes, along with global trends towards preventive healthcare and chronic disease management, drives demand for advanced diabetes care solutions tailored to local needs.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.